Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
BMC Cancer
|
February 23, 2024
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)
Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, et al.
Cancer Research and Treatment
|
September 2, 2015
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, et al.
The Korean Journal of Internal Medicine
|
February 9, 2021
2020 Korean guidelines for the management of metastatic prostate cancer
In-Ho Kim, Sang Joon Shin, Byung Woog Kang, et al.
Cancer Research and Treatment
|
June 16, 2026
Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19)
Young-Woong Won, Sun Young Rha, Jung Hye Kwon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 11, 2018
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)
Minkyu Jung, Min-Hee Ryu, Do Youn Oh, et al.
International Journal of Hematology
|
July 6, 2014
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
BMC Cancer
|
February 23, 2024
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)
Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, et al.
Cancer Research and Treatment
|
September 2, 2015
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, et al.
The Korean Journal of Internal Medicine
|
February 9, 2021
2020 Korean guidelines for the management of metastatic prostate cancer
In-Ho Kim, Sang Joon Shin, Byung Woog Kang, et al.
Cancer Research and Treatment
|
June 16, 2026
Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19)
Young-Woong Won, Sun Young Rha, Jung Hye Kwon, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 11, 2018
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)
Minkyu Jung, Min-Hee Ryu, Do Youn Oh, et al.
International Journal of Hematology
|
July 6, 2014
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, et al.
Page
of 7